Hepatitis C Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
CONCLUSION: Lean patients with cirrhosis and HCC present with larger tumors and are more often outside Milan criteria, reflecting cancer related cachexia from delayed diagnosis. Access to care for hepatitis C virus therapy and liver transplantation confer a survival benefit, but not overweight or obese BMI classifications.PMID:38577534 | PMC:PMC10989303 | DOI:10.4254/wjh.v16.i3.393 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Andrew Scott deLemos Jing Zhao Milin Patel Banks Kooken Karan Mathur Hieu Minh Nguyen Areej Mazhar Maggie McCarter Heather Burney Carla Kettler Naga Chalasani Samer Gawrieh Source Type: research

Trends in the prevalence of multiple chronic conditions among US adults with hypertension from 1999-2000 through 2017-2020
CONCLUSION: In 2017-2020, more than half of US adults with hypertension had ≥3 additional chronic conditions, a substantial increase from 20 years ago.PMID:38576398 | DOI:10.1093/ajh/hpae040 (Source: American Journal of Hypertension)
Source: American Journal of Hypertension - April 5, 2024 Category: Cardiology Authors: Chibuike J Alanaeme Lama Ghazi Oluwasegun P Akinyelure Ying Wen Ashley Christenson Bharat Poudel Erin E Dooley Ligong Chen Shakia T Hardy Kathryn Foti C Barrett Bowling Michelle T Long Lisandro D Colantonio Paul Muntner Source Type: research

Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional study
CONCLUSION: In the decentralised OAT setting of the canton of St Gallen, HCV Ab prevalence is high. Since HCV Ab and RNA screening uptake are markedly lower than in the centralised setting, potentially >40% of patients with chronic HCV are not diagnosed yet. HCV screening in the decentralised setting needs improvement, e.g. by increasing awareness and simplifying testing. High HCV treatment uptake and cure rates are possible in centralised and decentralised settings.PMID:38579293 | DOI:10.57187/s.3352 (Source: Swiss Medical Weekly)
Source: Swiss Medical Weekly - April 5, 2024 Category: General Medicine Authors: Kerstin Wissel Pietro Vernazza Stefan Kuster Katharina Hensel-Koch Andrea Bregenzer Source Type: research